A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
Clinical trial NCT06424899 · RECRUITING
Trial details
- NCT number
- NCT06424899
- Sponsor
- Zeng Jian
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-19
- Primary completion
- 2027-05-19
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.